Internal Medicine, Cardiovascular Disease · Amherst, NY
NPI
1578586251
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
190 Maple Rd
Amherst, NY, 14221
Phone (716) 580-3810
Groups this clinician bills Medicare through
Medicare paid, 2024
$139K
2,355 services
Medicare patients, 2024
817
Average age 75
Drug cost, 2024
$3.2M
9,850 prescriptions
Company payments, 2025
$992
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Muzamil I Rana was code 93000 (electrocardiogram), 522 times for 416 patients. In total Muzamil I Rana billed 2,355 services in 38 codes, and Medicare paid $139K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-12-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93000 Electrocardiogram | Office | 522 | 416 | $9.05 | $4,726 |
| 93306 Echocardiography (TTE/TEE) | Office | 283 | 278 | $124.66 | $35K |
| 99214 Office E&M - Established | Office | 196 | 166 | $85.82 | $17K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 160 | 40 | $5.70 | $911 |
| 93294 External Electrocardiographic Monitoring | Office | 117 | 41 | $17.49 | $2,046 |
| A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 102 | 51 | $72.17 | $7,362 |
| 99213 Office E&M - Established | Office | 100 | 92 | $56.59 | $5,659 |
| 93298 External Electrocardiographic Monitoring | Office | 90 | 21 | $66.32 | $5,969 |
| 93015 Electrocardiogram | Office | 76 | 76 | $41.37 | $3,144 |
| 99204 Office E&M - New | Office | 61 | 61 | $110.49 | $6,740 |
| 93297 External Electrocardiographic Monitoring | Office | 57 | 17 | $38.80 | $2,211 |
| 93224 Electrocardiogram | Office | 55 | 52 | $42.04 | $2,312 |
| 78452 Myocardial Perfusion Scan | Office | 53 | 53 | $296.14 | $16K |
| 99211 Office E&M - Established | Office | 41 | 30 | $16.54 | $678 |
| 99454 E&M - Miscellaneous | Office | 40 | 11 | $33.19 | $1,328 |
By year: 2022 $174K for 2,570 services; 2023 $131K for 2,188 services; 2024 $139K for 2,355 services.
Medicare prescription drug claims, 2024
In 2024, the drug Muzamil I Rana prescribed most often to Medicare patients was Metoprolol Succinate, with 1,464 prescriptions and refills. In total Muzamil I Rana wrote 9,850 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 1,464 | 3,870 | 424 | $31K |
| Amlodipine Besylate Generic | 827 | 2,214 | 275 | $8,100 |
| Rosuvastatin Calcium Generic | 700 | 1,986 | 238 | $14K |
| Eliquis Apixaban | 673 | 1,467 | 190 | $815K |
| Atorvastatin Calcium Generic | 517 | 1,469 | 169 | $8,720 |
| Furosemide Generic | 317 | 689 | 108 | $2,142 |
| Ezetimibe Generic | 307 | 841 | 113 | $7,067 |
| Digoxin Generic | 276 | 667 | 78 | $10K |
| Xarelto Rivaroxaban | 233 | 526 | 57 | $276K |
| Repatha Sureclick Evolocumab | 230 | 468 | 53 | $257K |
| Valsartan Generic | 219 | 555 | 70 | $5,084 |
| Bisoprolol Fumarate Generic | 216 | 548 | 61 | $7,868 |
| Lisinopril Generic | 203 | 550 | 66 | $2,401 |
| Nebivolol Hcl Generic | 173 | 367 | 45 | $9,590 |
| Entresto Sacubitril/Valsartan | 173 | 306 | 48 | $198K |
Brand drugs: 1,764 claims; generic drugs: 8,086 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Muzamil I Rana $992 ($992 in general payments such as food, travel and fees) from 19 companies. The largest payer was BridgeBio Pharma, Inc. with $185.
| Company | Payments | Amount |
|---|---|---|
| BridgeBio Pharma, Inc. BBIO | 4 | $185 |
| Edwards Lifesciences Corporation EW | 4 | $106 |
| Biotronik Inc. | 3 | $102 |
| Alnylam Pharmaceuticals Inc. ALNY | 4 | $85.99 |
| Merck Sharp & Dohme LLC MRK | 3 | $77.9 |
| Pfizer Inc. PFE | 3 | $68.23 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $62.9 |
| Recor Medical Inc | 2 | $43.94 |
| Kestra Medical Technology Services, Inc. | 1 | $37.31 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $36.67 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.